Medication-assisted Treatment (MAT) Market Size

Medication-assisted Treatment Market size is poised to reach USD 24.7 Million by the end of 2036, growing at a CAGR of 11.4% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of medication-assisted treatment was USD 13.3 Million. This can be attributed to the rising prevalence of substance use disorder among individuals. According to recent information, around 286 Million people aged 15-64 used drugs worldwide in 2020, a 26 percent increase over the past decade.

In addition, with the advancement in medications and therapies such as the availability of a variety of medications like methadone, naltrexone. There is a continuous improvement in behavioral therapies and pharmacological treatments which is enhancing the efficacy of medication-assisted treatment. Moreover, the development of long-acting formulations and innovative delivery methods is also driving the medication-assisted treatment market growth.